CELZ
Creative Medical Technology Holdings, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.11
+4.72%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
Market Cap
$7.32M
MomentumView details →
1D Return
+4.72%
YTD Return
−43.11%
RSI (14)
49.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
0.2x
Market Cap
$7.32M
RSI (14)
49.3
MomentumView details →
1D Return
+4.72%
YTD Return
−43.11%
SummaryUpdated Jun 1, 2026
Creative Medical Technology Holdings, Inc. (NASDAQ:CELZ) is a biotechnology company founded in 2015 and based in Phoenix, Arizona. The company focuses on developing adult stem cell treatments across multiple medical specialties including immunology, urology, orthopedics, and neurology. Since going public in November 2015, CELZ has been in the clinical development stage, working to advance its portfolio of stem cell-based therapies for various medical conditions ranging from erectile dysfunction to stroke recovery.
Similar companies
Latest newsMore news →
Creative Medical Technology Holdings completed enrollment and treatment of all patients across its FDA-cleared ADAPT clinical trial for CELZ-201/Olastrocel, including the opioid expansion cohort, advancing the therapy toward RMAT evaluation and Phase 3 planning for chronic lower back pain.15d agoCreative Medical Technology Holdings issued new inducement warrants to purchase 5,580,680 common shares at $1.60 per share after holders exercised existing warrants for aggregate gross proceeds of approximately $4.5 million.65d ago